Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 278
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
C
Observers at the Workshop on Antiprogestins: Assessing the Science April 13–14, 1993
Duane Alexander, M.D.
National Institute of Child Health and Human Development
National Institutes of Health
Freedolph Anderson, M.D.
The Jones Institute for Reproductive Medicine Norfolk, Virginia
Wendy Baldwin, Ph.D.
National Institute of Child Health and Human Development
National Institutes of Health
Jose Barzelatto, M.D.
The Ford Foundation
Marie Bass
Bass & Howe
Washington, D.C.
Gabriel Bialy
National Institute of Child Health and Human Development
National Institutes of Health
James Bilstad, M.D.
Food and Drug Administration
Deeda Blair
Lasker Foundation
Kristof Chwalisz, M.D.
Schering AG
Berlin, Germany
Francine Coeytaux, Ph.D.
Los Angeles, California
C. Edgar Cook, Ph.D.
Research Triangle Institute
Philip Corfman, M.D.
Food and Drug Administration
Horacio Croxatto, M.D.
Pontificia
Universidad Catolica de Chile
Robert B. Dickson, Ph.D.
Lombardi Cancer Research Center Georgetown University
Erlinda Etucbanas, M.D.
Berlex Laboratories Richmond, California
OCR for page 279
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
Robin Foldesy, Ph.D.
Gynopharma, Inc. Somerville, New Jersey
Marilynn Frederiksen, M.D.
Northwestern University
Henry Gabelnick, Ph.D.
CONRAD
Arlington, Virginia
George Gaines
National Institute of Child Health and Human Development
National Institutes of Health
Dr. Dominique Garrel
Centre de Recherche Hôtel-Dieu de Montréal
Mark Graham II, M.D.
Lineberger Cancer Center
University of North Carolina
Forrest Greenslade, Ph.D.
IPAS
Carrboro, North Carolina
Steven Grunberg, M.D.
Comprehensive Cancer Center
University of Southern California
Florence Haseltine, M.D., Ph.D.
National Institute of Child Health and Human Development
National Institutes of Health
R. Brian Heap, Ph.D., Sc.D., F.R.S.
AFRC—Institute of Animal Physiology and Genetics Research Cambridge, England
Jennifer Jackman
Feminist Majority Washington, D.C.
Harold Kaminetzky, M.D.
American College of Obstetricians and Gynecologists
Paul Lammers, M.D.
Organon West Orange, New Jersey
John Lamont, M.D.
McMaster University
Roderick Mackenzie
Gynopharma, Inc. Somerville, New Jersey
Carolyn Makinson
Andrew Mellon Foundation
Donald McDonnell, Ph.D.
Ligand Pharmaceuticals, Inc.
La Jolla, California
Irwin Merkatz, M.D.
Albert Einstein School of Medicine
Ruth Merkatz, Ph.D.
Food and Drug Administration
Ana Murphy, M.D.
Emory University
Mary Pendergast
Food and Drug Administration
Audrey Phillips, Ph.D.
R.W. Johnson Pharmaceutical Research Institute Raritan, New Jersey
Michael Policar, M.D., M.P.H.
Planned Parenthood Federation of America New York, New York
William Regelson, M.D.
Medical College of Virginia
OCR for page 280
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
Seymour Romney, M.D.
Albert Einstein School of Medicine
Sarah Samuels, Dr.P.H.
Henry J. Kaiser Family Foundation
Professor Gilbert Schiason
Hopital de Bicêtre Paris, France
Ekkehard Schillinger, M.D.
Schering AG Berlin, Germany
Sheldon Segal, Ph.D.
Population Council New York, New York
Solomon Sobel, M.D.
Food and Drug Administration
Jeff Spieler
Agency for International Development Washington, D.C.
Catherine Stika, M.D.
Northwestern University
Irene Stith-Coleman, Ph.D.
Congressional Research Service Washington, D.C.
Pamela Stratton, M.D.
National Institute of Child Health and Human Development
National Institutes of Health
Rosemarie Thau, Ph.D.
Population Council New York, New York
Helena von Hertzen, D.D.S., M.D.
World Health Organization Geneva, Switzerland
Charles Watlington, M.D., Ph.D.
Virginia Commonwealth University
Beverly Winikoff, M.D., M.P.H.
Population Council New York, New York
Susan Wood, Ph.D.
Congressional Caucus for Women's Issues Washington, D.C.
IOM STAFF
Kenneth Shine, M.D.
President
Enriqueta Bond, Ph.D.
Executive Officer
Michael Stoto, Ph.D.
Director, Division of Health Promotion and Disease Prevention
Ruth Bulger, Ph.D.
Director, Division of Health Sciences Policy
Molla Donaldson, M.S.
Study Director
Sarah Brown, M.P.H.
Senior Program Officer
Karen Foote
Commission on Behavioral and Social Sciences and Education (National Research Council)
Linda DePugh
Anna Mastroianni, J.D.
Terri Barba
Helen Rogers
Representative terms from entire chapter:
professor gilbert
